Therabionic, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer
Phase 2
Recruiting
- Conditions
- Pancreatic CancerMetastatic Adenocarcinoma
- Interventions
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- THERABIONIC INC.
- Target Recruit Count
- 46
- Registration Number
- NCT05776524
- Locations
- 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma
Phase 2
Recruiting
- Conditions
- Hepatocellular Carcinoma
- First Posted Date
- 2021-03-15
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- THERABIONIC INC.
- Target Recruit Count
- 166
- Registration Number
- NCT04797884
- Locations
- 🇺🇸
Tampa General Hospital, Tampa General Cancer Center, Tampa, Florida, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, United States
🇺🇸Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
News
No news found